REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

CANbridge Pharmaceuticals Inc. (Hong Kong) (China)

Main Activities: Forestry and Logging | Wood Product Manufacturing | Management of Companies and Enterprises
Secondary Activities: Coal and Other Mineral and Ore Merchant Wholesalers
Full name: CANbridge Pharmaceuticals Inc. Profile Updated: October 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Superb Summit International Group Limited is an investment holding company primarily engaged in the (i) exploitation and management of timber resources in China and (ii) marketing and sales of a wide range of timber products. The company was incorporated in 2001 and is headquartered in Hong Kong.

Headquarters
Suite 301, 3F, Timeloit, No. 17 Rong Chuang Road, Chaoyang District
Beijing; Beijing;

Contact Details: Purchase the CANbridge Pharmaceuticals Inc. (Hong Kong) report to view the information.

Website: http://www.canbridgepharma.com

Basic Information
Total Employees:
Purchase the CANbridge Pharmaceuticals Inc. (Hong Kong) report to view the information.
Outstanding Shares:
Purchase the CANbridge Pharmaceuticals Inc. (Hong Kong) report to view the information.
Registered Capital:
Purchase the CANbridge Pharmaceuticals Inc. (Hong Kong) report to view the information.
Financial Auditors:
Purchase the CANbridge Pharmaceuticals Inc. (Hong Kong) report to view the information.
Incorporation Date:
January 29, 2001
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
9.86%
Purchase this report to view the information.
7.5%
Purchase this report to view the information.
6.13%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
CAN bridge Pharmaceuticals Limited (Hong Kong SAR, China)
100%
CANbridge (Shanghai) Life Sciences Ltd.
100%
CANbridge (Suzhou) Bio-Pharma Co., Ltd.
100%
Company Performance
Financial values in the chart are available after CANbridge Pharmaceuticals Inc. (Hong Kong) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
4.05%▲
Total operating revenue
0.78%▲
Operating profit (EBIT)
-21.42%▼
EBITDA
-8.67%▼
Net Profit (Loss) for the Period
-13.34%▼
Total assets
-56.25%▼
Total equity
N/A
Operating Profit Margin (ROS)
-76.37%▼
Net Profit Margin
-45.26%▼
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
-0.76%▼
Cash Ratio
-0.76%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo